Q BIOMED PROVIDES UPDATE ON CORPORATE DEVELOPMENTS

Q BIOMED PROVIDES UPDATE ON CORPORATE DEVELOPMENTS Media Alert: CEO Interviewed on ‘The Stock Radio’ NEW YORK, September 1, 2016 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to report on its asset acquisition and an update on corporate development. While the summer months have been typically slow, we have made […]

Read More

MANNIN RESEARCH TO PARTICIPATE AT ARVO 2016 MEETING

New York,  April 4,2016- Q BioMed Inc. (QBIO), a biotechnology acceleration company announces that its technology partner Mannin Research Inc. will be attending the Association for Research in Vision and Ophthalmology (ARVO), which takes place from May 1-5, 2016 in Seattle Washington. Mannin Research executives will be meeting with its vendors and research partners. The […]

Read More

MANNIN RESEARCH TO PRESENT GLAUCOMA THERAPEUTICS TREATMENT AT MEDCITY INVEST CHICAGO APRIL 12 -13 2016

Management to Present Lead drug candidate to Industry and Venture Finance Executives NEW YORK, April 12, 2016 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce that its  license technology partner,  Mannin Research, will present at  MATTER Midwest University HealthTech Showcase on April 12 – 13th, 2016. Mannin Research will […]

Read More
Social media & sharing icons powered by UltimatelySocial